Press release October 2nd 2024 APOE genotyping allows assessment of a patient’s risk for adverse effects from new anti-amyloid therapy for Alzheimer’s Revvity, Inc. (NYSE: RVTY), announced today the launch of the in-vitro diagnostic assay in European countries that accept the CE mark, which will enable accurate genotyping of the APOE gene. APOE genotyping is […]

Experts worldwide have identified climate change as the greatest health challenge of the 21st century. There is growing evidence that climatic changes also favour the emergence, recurrence and spread of infectious diseases. However, the full extent of this worrying development is still insufficiently investigated. In a study from 2022, researchers analysed the literature and found

Does the following sound familiar? While walking in the woods, you find yourself admiring all of mother nature‘s gifts – many of which look more than delicious: … But you cannot help but think to yourself: „I better not pick the ones close to the ground”. After all, we have been taught to fear the

With passion for rheumatology! Indirect immunofluorescence assays (IFAs) such as for anti-nuclear antibody (ANA) testing are an important diagnostic tool in rheumatology. However, manual processing and evaluation of IFAs requires trained professionals and a lot of time. With innovative solutions and modern technologies, EUROIMMUN makes an important contribution to continuous development in immunofluorescence diagnostics and

Due to the high specificity of the results, indirect immunofluorescence assays (IFA) are still one of the most widely used diagnostic tools in autoimmunity. However, the challenges of processing these assays, in particular minimising manual effort and turnaround time while maintaining result specificity and quality, are constantly increasing. Fully automated processing using the UNIQO 160… EUROIMMUN